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Breast milk has been suggested as a signiﬁcant
potential source of lead exposure to nursing
infants (Silbergeld 1991), but relatively few
data exist with which to evaluate and quantify
this relationship. This phenomenon consti-
tutes a potential public health problem in
countries where environmental lead exposure
is continuing as well as in countries where
environmental lead exposure has declined
(Abadin et al. 1997). Previously, we reported
that maternal blood and bone lead levels are
both important determinants of lead in breast
milk (Ettinger et al. 2004). Lead from current
maternal exposure, as well as that accumu-
lated in bone from past environmental expo-
sures and subsequently released into blood, is
excreted into breast milk and thus may be
ingested by the nursing infant.
Studies of lead in human milk have found
concentrations ranging over three levels of
magnitude from < 1 to > 100 µg/L (ppb)
(Gulson et al. 1998; Namihira et al. 1993).
However, there are limited epidemiologic data
available regarding the potential exposure that
this represents for the breast-feeding infant.
There are some data from rodents on the
lactational transfer and uptake of lead in the
newborn. Kostial and Momcilovic (1974)
showed that the peak transfer of radiolabeled
lead in mice from mother to litter occurred
during lactation. Keller and Doherty (1980)
found that 25% of maternal bone lead bur-
den in mice was transferred to infant mice,
and most of this activity occurred during lac-
tation. Mouse breast milk was found to con-
centrate lead at around 25 times the level
circulating in plasma. Amount of lead trans-
ferred seems to vary considerably by species
(Oskarsson et al. 1995); however, there may
be more efficient absorption of lead by the
neonate compared with the adult (Oskarsson
et al. 1998; Palminger Hallén et al. 1996).
In humans, Rabinowitz et al. (1985)
described a log-linear dose–response relation-
ship between breast milk lead and infant blood
lead at 6 months of age (β = 3.0 µg/dL, SE =
1.1 µg/dL, r2 = 10%, p = 0.009). By examin-
ing the lead isotopic ratios in a small number
of infants born to recent immigrants to
Australia (and infants of Australian controls),
Gulson et al. (1998) found that for the first
60–90 days postpartum the contribution from
breast milk to blood lead in the infants varied
from 36 to 80%.
We evaluated the effect of breast milk
lead on infant blood lead levels to quantify
the dose–response relationship in a large,
population-based sample of infants exclu-
sively or partially breast-fed through 1 month
of age. We used a rigorous, well-validated
technique to collect, prepare, and analyze the
samples of breast milk to minimize the poten-
tial for contamination and maximize the
percent recovery of lead.
Materials and Methods
We conducted a cross-sectional study of 255
nursing infants at 1 month postpartum in
Mexico City. Subjects included infants born
to a subcohort of women recruited for later
participation in a randomized placebo-
controlled trial of calcium supplementation
during lactation. Informed consent, question-
naire information, and samples for the present
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Nursing infants may be exposed to lead from breast milk, but relatively few data exist with which
to evaluate and quantify this relationship. This route of exposure constitutes a potential infant
hazard from mothers with current ongoing exposure to lead as well as from mothers who have
been exposed previously due to the redistribution of cumulative maternal bone lead stores. We
studied the relationship between maternal breast milk lead and infant blood lead levels among
255 mother–infant pairs exclusively or partially breast-feeding through 1 month of age in Mexico
City. A rigorous, well-validated technique was used to collect, prepare, and analyze the samples of
breast milk to minimize the potential for environmental contamination and maximize the percent
recovery of lead. Umbilical cord and maternal blood lead were measured at delivery; 1 month after
delivery (± 5 days) maternal blood, bone, and breast milk and infant blood lead levels were
obtained. Levels of lead at 1 month postpartum were, for breast milk, 0.3–8.0 µg/L (mean ± SD,
1.5 ± 1.2); maternal blood lead, 2.9–29.9 µg/dL (mean ± SD, 9.4 ± 4.5); and infant blood lead,
1.0–23.1 µg/dL (mean ± SD, 5.5 ± 3.0). Infant blood lead at 1 month postpartum was signifi-
cantly correlated with umbilical cord (Spearman correlation coefﬁcient rS = 0.40, p < 0.0001) and
maternal (rS = 0.42, p < 0.0001) blood lead at delivery and with maternal blood (rS = 0.67,
p < 0.0001), patella (rS = 0.19, p = 0.004), and breast milk (rS = 0.32, p < 0.0001) lead at 1 month
postpartum. Adjusting for cord blood lead, infant weight change, and reported breast-feeding sta-
tus, a difference of approximately 2 µg/L (ppb; from the midpoint of the lowest quartile to the
midpoint of the highest quartile) breast milk lead was associated with a 0.82 µg/dL increase in
blood lead for breast-feeding infants at 1 month of age. Breast milk lead accounted for 12% of the
variance of infant blood lead levels, whereas maternal blood lead accounted for 30%. Although
these levels of lead in breast milk were low, they clearly have a strong inﬂuence on infant blood
lead levels over and above the influence of maternal blood lead. Additional information on the
lead content of dietary alternatives and interactions with other nutritional factors should be con-
sidered. However, because human milk is the best and most complete nutritional source for young
infants, breast-feeding should be encouraged because the absolute values of the effects are small
within this range of lead concentrations. Key words: blood lead, breast milk lead, breast-feeding,
KXRF bone lead, lactation. Environ Health Perspect 112:1381–1385 (2004). doi:10.1289/ehp.6616
available via http://dx.doi.org/ [Online 11 May 2004]study were obtained before the initiation of
calcium supplementation. All participating
mothers received a detailed explanation of the
study and counseling on reduction of lead
exposure. The research protocol was approved
by the human subjects committees of the
National Institute of Public Health of Mexico,
Harvard School of Public Health, and the
participating hospitals.
Data collection methods have been
described in detail elsewhere (Hernández-Avila
et al. 2003). Between January 1994 and June
1995, 2,945 potential study participants were
interviewed at three maternity hospitals in
Mexico City. Of these, 1,398 were eligible for
the trial. From the women identiﬁed as eligi-
ble, 629 (45%) agreed to participate in the
study. These women completed a baseline eval-
uation including a questionnaire that assessed
known risk factors for environmental lead
exposure, dietary assessment of nutrient intake,
and breast-feeding practices. At 1 month post-
partum (± 5 days), ﬁeld personnel visited study
participants at home to obtain anthropometric
measurements, blood, and breast milk samples.
Maternal bone lead was estimated by K X-ray
fluorescence (KXRF) at the research facility
at the American British Cowdray (ABC)
Hospital. Three hundred ten samples of breast
milk from the 1 month postpartum visit were
analyzed for lead content. This report is lim-
ited to the 255 subjects with both breast milk
and infant blood lead levels available at
1 month postpartum.
Blood lead. Blood lead measurements were
performed using graphite furnace atomic
absorption spectrophotometry (model 3000;
PerkinElmer, Norwalk, CT, USA) at the ABC
Hospital Trace Metal Laboratory according to a
technique described by Miller et al. (1987). The
laboratory participates in the Centers for Disease
Control and Prevention blood lead proﬁciency
testing program administered by the Wisconsin
State Laboratory of Hygiene (Madison, WI,
USA). The laboratory standardization program
provided external quality control specimens
varying from 2 to 88 µg/dL. Our laboratory
maintained acceptable precision and accuracy
over the study period (correlation = 0.98; mean
difference = 0.71 µg/dL; SD = 0.68).
Bone lead. We used a spot-source 109Cd
KXRF instrument constructed at Harvard
University and installed at the research facility
in Mexico City to measure maternal bone
lead. Thirty-minute in vivo measurements of
each subject’s mid-tibial shaft (representing
cortical bone) and patella (trabecular bone)
were obtained after each region had been
washed with a 50% solution of isopropyl
alcohol. The physical principles, technical
specifications, validation, and use of the
KXRF technique have been described in
detail elsewhere (Hu et al. 1991). The instru-
ment provides an estimate of the uncertainty
associated with each measurement. For quality
control, we excluded bone lead measurements
with uncertainty estimates that were > 10 and
15 µg lead/g mineral bone for tibia (n = 12) and
patella (n = 38), respectively, from the entire
cohort of 629 women. These measurements
generally reflect excessive patient movement
outside the measurement field or excessive
thickness of overlaying tissue and do not
produce acceptable results.
Breast milk lead. Breast milk samples were
collected at 1 month postpartum from lactat-
ing women using techniques to minimize
potential for environmental contamination.
Before manual expression of milk, the breast
was washed with deionized water, which also
was collected and analyzed for lead contami-
nation. Ten milliliters of milk was collected in
preleached polypropylene tubes. Samples were
frozen, shipped to the Channing Laboratory,
and stored at –30°C (Fisher IsoTempPlus,
New York, NY, USA) until analysis.
Breast milk sample preparation was per-
formed at University Research Institute for
Analytical Chemistry (Amherst, MA, USA),
and instrumental analysis was performed at the
Trace Metals Laboratory of Harvard School of
Public Health. Digestion was performed using
HNO3 acid in high-temperature high-pressure
asher (HPA; Anton Paar USA, Ashland, VA,
USA). Lead content in the samples was ana-
lyzed by isotope dilution–inductively coupled
plasma mass spectrometry (ID-ICPMS; Sciex
Elan 5000; PerkinElmer,) by methods previ-
ously described in detail (Ettinger et al. 2004).
The limit of detection for lead analysis in
breast milk by HPA digestion and ID-ICPMS
is 0.1 ng/mL (ppb) milk.
Statistical analysis. Univariate and bivari-
ate summary statistics and distributional plots
were examined for all variables. Infant blood
lead levels were highly positively skewed, so
for the subsequent regression analyses, the log
(base e)-transformed values of the dependent
variable were used. Possible associations
between infant blood lead and the indepen-
dent variables were separately explored with
bivariate linear regression models. Spearman
correlation coefficients with p-values are
reported. Characteristics of the participants
were compared by reported breast-feeding
practice (partial vs. exclusive) using Wilcoxon
sign rank/chi-square tests of equality of
two sample population means/proportions.
Extreme values of infant blood lead (n = 3)
and breast milk lead (n = 9) were identified
using the generalized extreme studentized
deviation many-outlier procedure (Rosner
1983) and excluded from the multivariate
regression analyses. We used multiple linear
regression models to describe the relationships
between infant blood lead, breast milk lead,
and the covariates of interest, which were
determined a priori based on biologic consid-
erations. Infant weight change (weight at
1 month minus birth weight) was used as a
surrogate for the amount of breast milk con-
sumed. The ﬁnal model for infant blood lead
included breast milk lead, umbilical cord lead
at delivery, breast-feeding status (exclusive vs.
partial), and infant weight change. Breast
milk lead was divided into quartiles, and the
midpoint of the quartile was used to predict
the infant blood lead level for exposure at that
level based on the final model for infant
blood lead. To explore potential nonlinear
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Table 1. Summary statistics for lead biomarkers among mothers and infants in the study.
Biomarker of lead exposure No. Mean ± SD Minimum Maximum
At delivery
Maternal blood lead (µg/dL) 251 8.7 ± 4.2 2.1 23.7
Umbilical cord lead (µg/dL) 222 6.7 ± 3.6 1.2 26.3
At 1 month postpartum
Breast milk lead (µg/L) 255 1.5 ± 1.2 0.3 8.0
Maternal blood lead (µg/dL) 255 9.4 ± 4.5 1.8 29.9
Maternal patella lead (µg/g)a 246 15.3 ± 15.0 < 1 67.2
Maternal tibia lead (µg/g)a 250 10.0 ± 10.4 < 1 76.6
Infant blood lead (µg/dL) 255 5.5 ± 3.0 1 23.1
aIncludes measurements with negative values: patella (n = 37), tibia (n = 34).
Figure 1. Smooth scatter plots (Lowess; bandwidth = 0.75) of infant blood lead by (A) maternal blood lead
and (B) breast milk lead at 1 month postpartum.
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) A Bassociations between breast milk lead and
infant blood lead levels, we examined the rela-
tions between the variables using generalized
additive models. All statistical analyses were
performed using Statistical Analysis System
(SAS) software (release 8.01; SAS Institute,
Inc., Cary, NC, USA) and S-PLUS (6.0 pro-
fessional edition for Windows; Insightful
Corp., Seattle, WA, USA).
Results
Summary statistics for the lead biomarkers
of mothers and infants in the study (n = 255)
are shown in Table 1. Levels of lead in breast
milk ranged from 0.3 to 8.0 µg/L (ppb).
Infant blood lead levels (mean ± SD) were
5.5 ± 3.0 µg/dL and ranged from 1.0 to
23.1 µg/dL. Figure 1 shows the unadjusted
relationships of maternal blood lead and
breast milk lead on infant blood lead levels at
1 month postpartum. Infant blood lead at
1 month postpartum was signiﬁcantly corre-
lated with umbilical cord (Spearman correla-
tion coefficient rS = 0.40, p < 0.0001) and
maternal (rS = 0.42, p < 0.0001) blood lead at
delivery and with concurrent maternal blood
(rS = 0.67, p < 0.0001), patella (rS = 0.19,
p = 0.004), and breast milk (rS = 0.32,
p < 0.0001) lead at 1 month postpartum
(Table 2).
On average, mothers in the study were
24.3 years of age (range, 14–40 years of age)
and had lived in Mexico City for 20 years
(range, 0.5–40 years). Forty percent of
women were primiparous. Of the 152 women
with prior pregnancies, 22% (n = 55) had
completed 12 or more months of total breast-
feeding of their previous infants.
Differences in maternal and infant charac-
teristics by reported breast-feeding practice
(exclusive n = 88 vs. partial n = 165) at
1 month postpartum are shown in Table 3.
Breast milk lead levels (mean µg/L ± SD) were
similar (p = 0.84) among women who reported
practicing exclusive breast-feeding (1.4 ± 1.1)
compared with women who practiced partial
lactation (1.5 ± 1.2). With respect to other
subject characteristics, subjects differed some-
what by lead-glazed ceramics use. Subjects who
were exclusively breast-feeding at 1 month
postpartum were less likely to have used lead-
glazed ceramics to store, prepare, or serve food
in the past (p = 0.03), with 69% of women
reporting past use of lead-glazed ceramics
compared with 81% of partially breast-feeding
mothers. In addition, those subjects who were
partially breast-feeding reported slightly
higher, although not statistically significant,
current use of lead-glazed ceramics (p = 0.08).
However, exclusively breast-feeding women
(10%) were more likely to have reported cur-
rent smoking or smoking during pregnancy
than were partially breast-feeding women
(3.6%; p = 0.03). Partially breast-feeding
women were more likely to be married (74 vs.
61%, p = 0.04) and reported slightly higher
dietary calcium intake (1,193 vs. 1,036 mg,
p = 0.002) than were women who were exclu-
sively breast-feeding at 1 month postpartum.
Figure 2 shows the nonparametric dose–
response relationship of maternal blood lead
and breast milk lead on infant blood lead levels
at 1 month postpartum from the generalized
additive model, adjusted for umbilical cord
blood lead (micrograms per deciliter), infant
weight change (grams), and breast-feeding
practice (exclusive vs. partial).
In multivariate linear regression models,
breast milk was a significant predictor
(p = 0.02) of infant blood lead after controlling
for umbilical cord lead, infant weight change,
and breast-feeding practice. Breast milk
accounted for 12% of the variance of infant
blood lead levels (Table 4), whereas maternal
blood lead accounted for 30% of the variance
of infant blood lead levels in a similar model
(data not shown). To predict the effect of
breast milk lead on infant blood lead level, we
calculated infant blood lead for each quartile of
breast milk exposure based on the ﬁnal model.
Adjusting for cord blood lead, infant weight
change, and reported breast-feeding practice,
we found that a difference of approximately
2 µg/L (from the midpoint of the lowest
Children’s Health | Effect of breast milk lead on infant blood lead
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Table 2. Correlation matrix for lead biomarkers.a
At delivery At 1 month postpartum
Umbilical Maternal Breast Maternal Maternal Maternal Infant
Biomarker of cord blood milk blood patella tibia blood
lead exposure (n = 222) (n = 220) (n = 255) (n = 255) (n = 246) (n = 250) (n = 255)
At delivery
Umbilical cord 1.00 0.82 0.34 0.51 0.019 0.12 0.40
p < 0.0001 p < 0.0001 p < 0.0001 p = 0.006 p = 0.07 p < 0.0001
Maternal blood 1.00 0.36 0.56 0.22 0.18 0.42
p < 0.0001 p < 0.0001 p = 0.0006 p = 0.006 p < 0.0001
At 1 month postpartum
Breast milk 1.00 0.42 0.14 –0.005 0.32
p < 0.0001 p = 0.03 p = 0.94 p < 0.0001
Maternal blood 1.00 0.30 0.19 0.67
p < 0.0001 p < 0.0001 p < 0.0001
Maternal patella 1.00 0.27 0.19
p < 0.0001 p = 0.004
Maternal tibia 1.00 0.08
p = 0.2
Infant blood 1.00
aSpearman correlation coefﬁcients; prob > |r| under H0; rho = 0.
Table 3. Maternal and infant characteristics by reported breast-feeding practice.
Reported breast-feeding practice
Exclusive lactation Partial lactation
Characteristic No. Mean ± SD No. Mean ± SD p-Valuea
At delivery
Umbilical cord lead (µg/dL) 78 6.4 ± 2.9 143 6.9 ± 3.9 0.26
Maternal blood lead (µg/dL) 86 8.1 ± 3.8 164 9.0 ± 4.4 0.09
Infant birth weight (g) 88 3,140 ± 372 165 3,121 ± 380 0.71
Infant birth length (cm) 86 50.6 ± 2.1 162 50.3 ± 2.3 0.30
Infant head circumference (cm) 84 34.0 ± 1.4 157 33.9 ± 1.4 0.45
At 1 month of age (infant)
Blood lead (µg/dL) 88 5.4 ± 3.2 165 5.6 ± 3.0 0.54
Weight (g) 87 4,263 ± 516 165 4,178 ± 534 0.22
Length (cm) 88 53.5 ± 2.1 165 53.6 ± 2.0 0.79
At 1 month postpartum (maternal)
Breast milk lead (µg/L) 88 1.4 ± 1.1 165 1.5 ± 1.2 0.85
Blood lead (µg/dL) 88 9.4 ± 4.8 165 9.5 ± 4.3 0.82
Patella lead (µg/g) 85 15.4 ± 12.6 159 15.4 ± 16.1 0.98
Tibia lead (µg/g) 87 9.9 ± 9.5 164 10.0 ± 10.9 0.96
Age (years) 88 24.6 ± 5.4 165 24.2 ± 4.7 0.54
Years living in Mexico City 88 19.2 ± 9.4 165 20.7 ± 8.2 0.20
Education (years) 85 8.8 ± 3.1 165 9.2 ± 3.0 0.30
Married (%) 88 61 165 74 0.04
Estimated calcium intake (mg) 88 1,036 ± 358 164 1,193 ± 397 0.002
Previous lactation > 12 months (%) 88 28.4 165 18.2 0.06
No. of pregnancies 88 2.2 ± 1.3 165 2.0 ± 1.2 0.22
Primiparous (%) 88 35.2 165 43.6 0.19
Current use of lead-glazed ceramics (%) 88 34.1 165 45.5 0.08
Past use of lead-glazed ceramics (%) 88 69.3 165 81.2 0.03
Current smoking or during pregnancy (%) 88 10.2 165 3.6 0.03
ap-Value from Wilcoxon sign rank test/chi-square test of equality of two sample population means/proportions.quartile to the midpoint of the highest quar-
tile) of breast milk lead was associated with a
0.82-µg/dL increase in blood lead for infants at
1 month of age (Figure 3). This effect was
almost identical among the exclusive and par-
tial breast-feeding groups, so the combined
data are presented.
Discussion
From birth to 6 months, the infant’s exposure
to lead is typically dominated by dietary
sources. Although the levels of lead in breast
milk reported here were low, they clearly had
a strong inﬂuence on infant blood lead levels
over and above the influence of maternal
blood lead. In our study, breast milk lead
accounted for 12% of the variance of infant
blood lead levels at 1 month of age. In the
only other large-scale study of breast milk and
infant blood lead levels, milk lead accounted
for 10% of the variance in 6-month blood
lead (Rabinowitz et al. 1985).
It is important to estimate the contribu-
tion from the non–breast milk sources to total
lead exposure from dietary intake. Rabinowitz
et al. (1985) found breast milk to be the
strongest correlate of 6-month blood leads,
whereas formula lead correlated poorly with
infant blood lead levels. Gulson et al. (1998)
showed that the contribution of formula to
infant blood lead varied from 24 to 68% in
formula-fed infants. Therefore, it would have
been important to document the sources and
amount of lead in diet (other than from breast
milk) consumed by infants in this population.
Our study was completed during the vol-
untary removal of lead soldered cans from the
market in Mexico (De León 1996), so lead in
canned infant formula may have been an addi-
tional source. We can only speculate that the
contribution to lead exposure from foods and
beverages used as alternatives to or in combina-
tion with breast milk may have been similar to
or greater than that of breast milk. Although
there may be more lead in infant formula, the
relative bioavailability of such lead may be less
than that of lead in breast milk. For example, it
has been documented that iron is more readily
absorbed from breast milk than from infant
formula (Lonnerdal 1985).
Estimating the potential lead dose to infants
from breast milk requires information about
the quantity of breast milk consumed per day
and the duration over which breast-feeding
occurs (U.S. EPA 1997). Average intakes are
about 750–800 g/day (range, 450–1,200 g/day)
for the first 4–5 months of life [Institute of
Medicine (IOM) 1991]. However, infant birth
weight and nursing frequency have been shown
to inﬂuence the rate of intake (IOM 1991). We
attempted to control for consumption using
infant weight change from birth to 1 month as
a surrogate in our analyses.
It may also be important to estimate the
contribution from the nondietary sources of
lead to total body burden of young children.
Although it is widely assumed that infant expo-
sures to lead during the ﬁrst 4–6 months of life
are derived from diet, Manton et al. (2000)
showed that lead dust contributed to exposure
in U.S. infants in the first 4 months of life.
However, lead dust is not a common source of
exposure in Mexico. Also, neonatal bone
turnover is a potential endogenous source of
lead in infant blood (Gulson et al. 2001).
Our previous research (Hernández-Avila
et al. 1996; Hu et al. 1996) and the research
of others (Gulson et al. 1997; Rothenberg
et al. 2000) have clearly shown that maternal
bone stores of lead are mobilized to a marked
degree during lactation. Breast-feeding prac-
tices and maternal bone lead are important
predictors of maternal blood lead levels over
the course of lactation (Téllez-Rojo et al.
2002). Previously, we reported that maternal
blood and bone lead levels are both important
determinants of lead in breast milk (Ettinger
et al. 2004). Our data suggest that despite the
potential for lead exposure, even among this
population of women who have been rela-
tively highly exposed, levels of lead in breast
milk are low. However, we have demon-
strated here that breast milk lead levels are
highly inﬂuential on infant blood lead levels
at 1 month of age. This is a cross-sectional
analysis at 1 month postpartum and cannot
evaluate changes in breast milk, infant blood,
and bone lead levels over the course of lacta-
tion. It will be important to determine whether
the degree of this inﬂuence changes over the
course of lactation.
Due to the unique nutritional characteris-
tics of human milk, breast-feeding is thought
to be the optimal mode of nutrient delivery to
term infants [American Academy of Pediatrics
1997; IOM 1991; World Health Organization
(WHO) 1995]. Better understanding of the
potential for neonatal exposure, including
kinetics in the lactating mother and knowledge
about alternative dietary sources of lead, is
needed for risk assessment. Given the correla-
tion of breast milk lead levels with maternal and
infant blood lead levels, milk lead can be used
as an indicator of both maternal and neonatal
exposure (Hallén et al. 1995). Additional
information on the lead content of dietary
alternatives should be investigated in compar-
ison with breast milk levels in a speciﬁc popu-
lation and interactions with other nutritional
factors should also be considered. This high-
lights the need to further investigate inter-
ventions that may reduce lead exposure from
endogenous sources. Because bone lead has a
half-life of years to decades, infants will
continue to be at risk for exposure long after
environmental sources of lead have been
abated. In addition, efforts to reduce ongoing
environmental exposure to lead should be
continued, and ways to mitigate the effects
of past exposures should be investigated.
However, because human milk is the best and
most complete nutritional source for young
infants, breast-feeding should be encouraged
Children’s Health | Ettinger et al.
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Table 4. Multivariate regressions for infant blood lead.a
β-coefﬁcient SE p-Value Partial R2b
Intercept 1.06 0.15 < 0.0001 —
Breast milk leadc (µg/L) 0.10 0.04 0.02 0.12
Umbilical cord blood lead (µg/dL) 0.05 0.009 < 0.0001 0.11
Infant weight change (g) –0.00009 0.00007 0.2 0.007
Breast-feeding practiced 0.09 0.06 0.15 0.015
aInfant blood lead levels log (base e) transformed, n = 3 extreme outliers excluded. bAdjusted model R2 = 0.2259. cBreast
milk lead n = 9, extreme outliers removed. dExclusive lactation = reference group.
Figure 2. Generalized additive model-adjusted
dose–response function for log-scaled infant blood
lead and breast milk lead concentrations at
1 month postpartum adjusted for umbilical cord
blood lead, infant weight change, and breast-feed-
ing practice. The dashed lines represent 95%
pointwise conﬁdence intervals.
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Figure 3. Geometric mean infant blood lead level
(µg/dL) predicted at each level of breast milk lead.
The midpoints of quartile 1 = 0.53 µg/L; quartile 2 =
0.83; quartile 3 = 1.28; quartile 4 = 2.34. A difference
of approximately 2 µg/L (ppb; from the midpoint of
the lowest quartile to the midpoint of the highest
quartile) breast milk lead was associated with a
0.82-µg/dL increase in blood lead for breast-feeding
infants at 1 month of age.
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24 3 1because the absolute values of the effects are
small within this range of lead concentrations.
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